The present invention includes arginase enzyme inhibitors, compositions comprising these arginase inhibitors, and methods of treating or diagnosing conditions characterized either by abnormally high arginase activity or abnormally low nitric oxide levels in a mammal, comprising administering compositions of the invention to the mammal.
申请公布号
HK1213769(A1)
申请公布日期
2016.07.15
申请号
HK20160101689
申请日期
2016.02.17
申请人
AstraZeneca AB
发明人
TOMCZUK, Bruce, Edward BE;OLSON, Gary, Lee GL;POTTORF, Richard, Scott RS;WANG, Jane J;NALLAGANCHU, Bhaskara, Rao BR